Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
about
HIV infection and cardiovascular diseaseHypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional studyHypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western KenyaPrevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patientsChromium Therapy for Insulin Resistance Associated with HIV-DiseaseReduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adultsNutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines.RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected PatientsHIV infection and coronary heart disease: an intersection of epidemicsBody composition and metabolic changes in HIV-infected patientsRisk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study.Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART.Pathogenesis and treatment of HIV lipohypertrophyEffects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy.Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort StudyInsulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.Progression of coronary artery calcium in men affected by human immunodeficiency virus infection.Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues.Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.Cardiovascular disease in patients with HIVFrom lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
P2860
Q27008915-EA2BF7C2-10AF-4D04-9A28-587451606EDBQ28744647-650CA571-810C-4AA6-AB5D-06C7CB297926Q33968354-491EE242-71B9-4C1D-AB21-D456352F1248Q34079798-1FEF08A3-6B18-4F13-B964-30E60A016B5DQ34390688-EFBBA0A9-D6B4-42E8-AC18-B326074C8291Q34637395-0D8587A4-FB41-4254-8420-28E72A659C15Q34718269-AC78674E-DD2F-44CF-95BA-59A4C83CAFDAQ35578707-19EB49E4-1DEF-411D-BC6A-11C9FFE1184EQ35607320-93AA7BFF-6943-4254-BCF0-FA42022AD858Q35916560-7B7AC25A-F5AA-43EC-91FB-5ACF1D451847Q35949941-3BE7BF3E-F4E1-4B5E-8FC6-554B1067443EQ35949965-1D1D9429-EA9B-446D-A146-C8B016198602Q36127886-7EBDCF6D-6B05-4482-8625-F50008EF0D76Q36282430-71B3AA2D-5441-422D-A355-5BDDB6CEA259Q36900984-196CA4B0-9689-4305-B602-BAE3F796A104Q36903976-5C69DC56-0FC7-457E-9F31-CD245616EA9EQ37025609-AB304F6E-58F5-45EF-A5DF-D2BB8CA4491EQ37091664-76CF64A0-403A-4C85-A5EE-58D0CE6EFA57Q38108736-07C6FD4B-79C1-4065-B7C6-4A6CE1D251D5Q38936060-122A1704-5E23-4A46-AA87-18BA9BED3BDEQ39035129-DF39BF08-AC2F-4FA5-9E52-FA8DCA2C833BQ42241185-D16A2DE7-F944-4B95-A1FE-6F4C7EBFDE5BQ42278370-909BBBE1-569D-449F-8F82-802DBF9FC6B6Q45356311-4A6D74D0-9059-47FD-A079-2C29C6AA3306Q46361539-BA523F19-057E-4B82-8C33-1F4E5D38A729Q51008407-FA00D994-6CE6-4ED0-A23C-D6C0B7AED67FQ57681411-403C77CC-8AB6-4B45-975C-9C0C319401E4Q58798012-28C6339C-9D13-469A-96B5-72507D075D2C
P2860
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@en
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@nl
type
label
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@en
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@nl
prefLabel
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@en
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@nl
P2093
P50
P1433
P1476
Lipodystrophy and anti-retrovi ...... iency virus infected subjects.
@en
P2093
Antonella Lattanzi
Chiara Stentarelli
Federica Carli
Frank Palella
Gabriella Orlando
Guido Ligabue
Nikolaos Alexopoulos
Paolo Raggi
Stefano Zona
P304
P356
10.1016/J.ATHEROSCLEROSIS.2009.06.011
P577
2009-06-18T00:00:00Z